VGR Australia VGR Australia

Enclomiphene
Enclomiphene

0.71
Research indicates this molecule helps with endogenous testosterone production by stimulating the pituitary gland.
Ingredient
Enclomiphene
Category
Hormone Therapy
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Enclomiphene
Reference Brand
Ency
Product Origin
Generic Product
Product Form
Tablet, Capsule
Regulatory Classification
Rx
Primary Category
Hormones
Product Category
Estrogen Receptor Antagonist
Pharmacological Class
SERM
Clinical Indications
Hypogonadism
Manufacturer Description
Formulated for hypogonadism to manage testosterone production and support endocrine health.
Mechanism of Action
Enclomiphene is the trans-isomer of clomiphene. It antagonizes estrogen receptors in the pituitary gland, removing feedback inhibition of gonadotropins. This increases the release of LH and FSH, stimulating the testes to produce endogenous testosterone.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Hepatic impairment, Uncontrolled adrenal dysfunction, Hypersensitivity to enclomiphene
Severe Adverse Events
Thromboembolism, Severe vision loss, Anaphylaxis — requires immediate medical attention
Common Side Effects
Headache, Nausea, Dizziness
Uncommon Side Effects
Visual disturbances, Mood changes, Joint pain
Drug Interactions
Alcohol
Age Restrictions
Indicated for use in adult males only.
Storage Guidelines
Store at room temperature.
Related Products
Clomid
Information related to Enclomiphene is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
How to order Contraceptives UK - Desogestrel Ethinyl Estradiol Pill